CLDN4 and ovarian carcinoma: To test our hypothesis that the novel activities we have described for claudin-4 in normal epithelial cells are functionally contributing to ovarian tumor cell behavior, we used the DFYNP peptide as well as silencing of claudin-4 gene expression to examine changes in apoptotic response and migration of ovarian cancer cells.